Request Demo
Last update 05 Apr 2026
BPI-572270
Last update 05 Apr 2026
Overview
Basic Info
Drug Type Small molecule drug, Non-degrading molecular glue |
Synonyms- |
Target |
Action inhibitors |
Mechanism RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with BPI-572270NCT07435038
A Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS.
100 Clinical Results associated with BPI-572270
Login to view more data
100 Translational Medicine associated with BPI-572270
Login to view more data
100 Patents (Medical) associated with BPI-572270
Login to view more data
100 Deals associated with BPI-572270
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colorectal Cancer | Phase 2 | - | 12 Feb 2026 | |
| Non-Small Cell Lung Cancer | Phase 2 | - | 12 Feb 2026 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 11 Feb 2026 | |
| Pancreatic Ductal Adenocarcinoma | Phase 2 | China | 11 Feb 2026 | |
| RAS mutant Colorectal Cancer | Phase 2 | China | 11 Feb 2026 | |
| RAS Mutation Non-Small Cell Lung Cancer | Phase 2 | China | 11 Feb 2026 | |
| Advanced Lung Non-Small Cell Carcinoma | IND Approval | China | 27 Jan 2026 | |
| Metastatic Pancreatic Cancer | IND Approval | China | 27 Jan 2026 | |
| Advanced Pancreatic Adenocarcinoma | IND Application | China | 21 Nov 2025 | |
| Metastatic Colorectal Carcinoma | IND Application | China | 21 Nov 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free